🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

3M wins injunction against mask seller accused of price gouging

Published 2020-05-05, 01:29 p/m
© Reuters. FILE PHOTO: Various N95 respiration masks at a laboratory of 3M, that has been contracted by the U.S. government to produce extra marks in response to the country's novel coronavirus outbreak, in Maplewood, Minnesota
MMM
-

By Jonathan Stempel

NEW YORK (Reuters) - 3M Co (N:MMM) won an injunction from a federal judge against a New Jersey company it accused of illegally using its trademarks to sell 3M-branded N95 respirator masks at inflated prices to exploit the coronavirus pandemic.

U.S. District Judge Loretta Preska in Manhattan on Monday blocked Performance Supply LLC of Englishtown, New Jersey from using 3M's name and logo, or posing as an authorized 3M distributor, to help sell masks.

3M, based in St. Paul, Minnesota, is the world's largest maker of N95 masks, which are designed to filter 95% of airborne particles.

It said it sued after learning that Performance Supply tried to sell 7 million masks to New York City's Office of Citywide Procurement for $43.85 million, or an average $6.26 each, according to its invoice.

3M said the markup was roughly five times its list prices of $1.02 to $1.31 per mask, depending on the model, and amounted to "extreme" price gouging.

Performance Supply could not immediately be reached on Tuesday for comment. 3M has filed at least 10 similar lawsuits in several courts, and the preliminary injunction is its first.

"The goal from the start has been to try to get rid of 'static' in the system so that procurement officers don't have to sort through misleading offers, and we can get our respirators where they need to be," William Childs, a senior counsel at 3M, said in an interview.

Judge Preska said Performance Supply's conduct would likely irreparably harm 3M's reputation if it continued.

She also said an injunction served the public interest, and governments, hospitals and other healthcare providers should not have to squander resources to investigate the masks' origins.

"When lives are at stake and time is of the essence, as is clearly the case in this crisis, the public interest demands accountability," Preska wrote.

New York City is part of the epicenter for the pandemic within the United States.

© Reuters. FILE PHOTO: Various N95 respiration masks at a laboratory of 3M, that has been contracted by the U.S. government to produce extra marks in response to the country's novel coronavirus outbreak, in Maplewood, Minnesota

3M in January doubled its annual production rate of N95 masks to 1.1 billion. Chief Executive Mike Roman said last week that the company is working with the U.S. Department of Defense to boost annual production to 2 billion by year end.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.